Beigene (NASDAQ:ONC) Releases Earnings Results, Misses Estimates By $0.55 EPS

Beigene (NASDAQ:ONC) issued its quarterly earnings data on Thursday. The company reported ($1.43) EPS for the quarter, missing analysts’ consensus estimates of ($0.88) by ($0.55), Zacks reports. The business had revenue of $1.13 billion during the quarter, compared to analysts’ expectations of $1.09 billion. Beigene had a negative return on equity of 25.12% and a negative net margin of 25.94%. Beigene updated its FY 2025 guidance to EPS.

Beigene Stock Performance

Beigene stock opened at $271.80 on Friday. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.93 and a quick ratio of 1.72. The stock has a market capitalization of $26.60 billion, a PE ratio of -32.99, a PEG ratio of 7.73 and a beta of 0.63. Beigene has a 12-month low of $126.97 and a 12-month high of $287.88.

Wall Street Analyst Weigh In

Separately, Macquarie lifted their target price on Beigene from $259.00 to $313.00 and gave the stock an “outperform” rating in a report on Friday.

Insider Buying and Selling at Beigene

In related news, COO Xiaobin Wu sold 21,267 shares of the firm’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $240.07, for a total value of $5,105,568.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Chan Henry Lee sold 1,202 shares of the stock in a transaction on Friday, February 21st. The stock was sold at an average price of $258.04, for a total value of $310,164.08. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 790,950 shares of company stock worth $204,616,547. 7.43% of the stock is currently owned by insiders.

About Beigene

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.